87 related articles for article (PubMed ID: 33754476)
1. Primary transoral robotic surgery +/- adjuvant therapy for oropharyngeal squamous cell carcinoma-A large observational single-centre series from the United Kingdom.
O'Hara J; Warner L; Fox H; Hamilton D; Meikle D; Counter P; Robson A; Goranova R; Iqbal S; Kelly C; Robinson M; Paleri V
Clin Otolaryngol; 2021 Sep; 46(5):1005-1012. PubMed ID: 33754476
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of transoral robotic surgery for early-stage oropharyngeal squamous cell carcinoma with low rates of adjuvant therapy: A consecutive single-institution study from 2013 to 2020.
Meldgaard Justesen M; Kronberg Jakobsen K; Fenger Carlander AL; Hjordt Holm Larsen M; Wessel I; Kiss K; Friborg J; Ibrahim Channir H; Rubek N; Grønhøj C; von Buchwald C
Oral Oncol; 2024 May; 152():106783. PubMed ID: 38569317
[TBL] [Abstract][Full Text] [Related]
3. Transoral robotic surgery and neck dissection alone for head and neck squamous cell carcinoma: Influence of resection margins on oncological outcomes.
Warner L; O'Hara JT; Lin DJ; Oozeer N; Fox H; Meikle D; Hamilton D; Iqbal MS; Robinson M; Paleri V
Oral Oncol; 2022 Jul; 130():105909. PubMed ID: 35636080
[TBL] [Abstract][Full Text] [Related]
4. Preoperative Circulating Tumor HPV DNA and Oropharyngeal Squamous Cell Disease.
Lam D; Sangal NR; Aggarwal A; Rajasekaran K; Cannady SB; Basu D; Chalian A; Weinstein G; Brody RM
JAMA Otolaryngol Head Neck Surg; 2024 May; 150(5):444-450. PubMed ID: 38573644
[TBL] [Abstract][Full Text] [Related]
5. Differences in Functional and Survival Outcomes Between Patients Receiving Primary Surgery vs Chemoradiation Therapy for Treatment of T1-T2 Oropharyngeal Squamous Cell Carcinoma.
Amin DR; Philips R; Bertoni DG; Mastrolonardo EV; Campbell DJ; Agarwal AM; Tekumalla S; Urdang ZD; Luginbuhl AJ; Cognetti DM; Curry JM
JAMA Otolaryngol Head Neck Surg; 2023 Nov; 149(11):980-986. PubMed ID: 37422846
[TBL] [Abstract][Full Text] [Related]
6. [Preliminary outcomes of neoadjuvant chemoimmunotherapy combined with transoral robotic surgery for locally advanced oropharyngeal squamous cell carcinoma].
Chen RH; Liang FY; Han P; Lin PL; Lin XJ; Wang JY; Kong XW; Huang XM
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2024 Apr; 59(4):329-334. PubMed ID: 38599642
[No Abstract] [Full Text] [Related]
7. Cost-utility of two minimally-invasive surgical techniques for operable oropharyngeal cancer: transoral robotic surgery versus transoral laser microsurgery.
Parimbelli E; Soldati F; Duchoud L; Armas GL; de Almeida J; Broglie M; Quaglini S; Simon C
BMC Health Serv Res; 2021 Oct; 21(1):1173. PubMed ID: 34711226
[TBL] [Abstract][Full Text] [Related]
8. Transoral Surgery in HPV-Positive Oropharyngeal Carcinoma: Oncologic Outcomes in the Veterans Affairs System.
Faraji F; Kumar A; Voora R; Soliman SI; Cherry D; Courtney PT; Finegersh A; Guo T; Cohen E; Califano JA; Mell L; Rose B; Orosco RK
Laryngoscope; 2024 Jan; 134(1):207-214. PubMed ID: 37255050
[TBL] [Abstract][Full Text] [Related]
9. Comparative effectiveness trial of transoral head and neck surgery followed by adjuvant radio(chemo)therapy versus primary radiochemotherapy for oropharyngeal cancer (TopROC).
Bußmann L; Laban S; Wittekindt C; Stromberger C; Tribius S; Möckelmann N; Böttcher A; Betz CS; Klussmann JP; Budach V; Muenscher A; Busch CJ
BMC Cancer; 2020 Jul; 20(1):701. PubMed ID: 32727416
[TBL] [Abstract][Full Text] [Related]
10. De-Escalated Adjuvant Therapy After Transoral Robotic Surgery for Human Papillomavirus-Related Oropharyngeal Carcinoma: The Sinai Robotic Surgery (SIRS) Trial.
Miles BA; Posner MR; Gupta V; Teng MS; Bakst RL; Yao M; Misiukiewicz KJ; Chai RL; Sharma S; Westra WH; Kim-Schulze S; Dayal B; Sobotka S; Sikora AG; Som PM; Genden EM
Oncologist; 2021 Jun; 26(6):504-513. PubMed ID: 33675133
[TBL] [Abstract][Full Text] [Related]
11. Positive Deep Initial Incision Margin Affects Outcomes in TORS for HPV+ Oropharynx Cancer.
Kejner A; Gentile C; Porterfield Z; Carroll WR; Buczek EP
Laryngoscope; 2023 May; 133(5):1132-1137. PubMed ID: 35809041
[TBL] [Abstract][Full Text] [Related]
12. Robotic lateral oropharyngectomy following diagnostic tonsillectomy is oncologically safe in patients with high risk human papillomavirus related squamous cell cancer.
Siddiq S; Cartlidge D; Stephen S; Sathasivam HP; Fox H; O'Hara J; Meikle D; Iqbal MS; Kelly CG; Robinson M; Paleri V
Eur Arch Otorhinolaryngol; 2018 Jul; 275(7):1853-1860. PubMed ID: 29754260
[TBL] [Abstract][Full Text] [Related]
13. Role of TORS as De-Escalation Strategy in HPV-Related Oropharyngeal Cancer, What We Need to Know.
Molteni G; Bassani S; Arsie AE; Zampieri E; Mannelli G; Orlandi E; Bossi P; De Virgilio A
Healthcare (Basel); 2024 May; 12(10):. PubMed ID: 38786424
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of transoral robotic surgery for early-stage oropharyngeal squamous cell carcinoma with low rates of adjuvant therapy: A consecutive single-institution study from 2013 to 2020.
Dharmalingam Jothinathan MK
Oral Oncol; 2024 May; 152():106811. PubMed ID: 38636137
[No Abstract] [Full Text] [Related]
15. Characterizing postoperative physiologic swallow function following transoral robotic surgery for early stage tonsil, base of tongue, and unknown primary human papillomavirus-associated squamous cell carcinoma.
Ottenstein L; Cornett H; Switchenko JM; Nathan M; Thomas S; Gillespie AI; McColloch N; Barrett T; Studer MB; Brinkman M; Kaka AS; Boyce BJ; Ferris RL; Aiken AH; El-Deiry M; Beitler JJ; Patel MR
Head Neck; 2021 May; 43(5):1629-1640. PubMed ID: 33547716
[TBL] [Abstract][Full Text] [Related]
16. Letter to Editor: Comparison of margins and survival between transoral robotic surgery (TORS) and non-robotic endoscopic surgery for oropharyngeal cancer.
Wong BYW; Jose J
Am J Otolaryngol; 2024; 45(3):104225. PubMed ID: 38246100
[No Abstract] [Full Text] [Related]
17. The Impact of Hospital Safety-Net Burden Status on Patients with HPV-Positive Oropharyngeal Cancer.
Gilja S; Kumar A; Kapustin D; Su V; Rubin SJ; Chai R; Roof SA; Khan MN
Laryngoscope; 2024 Apr; 134(4):1733-1740. PubMed ID: 37933810
[TBL] [Abstract][Full Text] [Related]
18. Transoral robotic surgery for residual and recurrent oropharyngeal cancers: Exploratory study of surgical innovation using the IDEAL framework for early-phase surgical studies.
Paleri V; Fox H; Coward S; Ragbir M; McQueen A; Ahmed O; Meikle D; Saleh D; O'Hara J; Robinson M
Head Neck; 2018 Mar; 40(3):512-525. PubMed ID: 29244229
[TBL] [Abstract][Full Text] [Related]
19. Transoral Robotic Surgery and Radiation Volume Deintensification in Unknown Primary Squamous Cell Carcinoma of the Neck: The Phase 2 FIND Nonrandomized Controlled Trial.
de Almeida JR; Martino R; Hosni A; Goldstein DP; Bratman SV; Chepeha DB; Waldron JN; Weinreb I; Perez-Ordonez B; Yu E; Metser U; Hansen AR; Xu W; Su SJ; Kim J
JAMA Otolaryngol Head Neck Surg; 2024 Apr; ():. PubMed ID: 38602692
[TBL] [Abstract][Full Text] [Related]
20. Risk of recurrence after neoadjuvant chemotherapy and transoral robotic surgery in patients with oropharynx cancer that avoid adjuvant radiation.
Pershad AR; Thakkar PG; Goodman JF; Joshi A; Steinberg SM; Allen CT; Floudas CS
Cancer Med; 2024 Apr; 13(7):e7146. PubMed ID: 38581118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
